Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Elektroninen E-kirja |
| Kieli: | englanti |
| Julkaistu: |
Hamburg, Germany :
Anchor Academic Publishing,
2014.
|
| Aiheet: | |
| Linkit: | An electronic book accessible through the World Wide Web; click to view |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
Samankaltaisia teoksia: Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
- Continuous processing in pharmaceutical manufacturing /
- Biomedical chromatography
- Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
- WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
- The war against counterfeit medicine my story /
- Analytical method validation and instrument performance verification